64 related articles for article (PubMed ID: 7733108)
1. Once or twice daily doses of proton pump inhibitor in treating Barrett's esophagus?
Savarino V; Mela GS; Zentilin P; Celle G; Vigneri S
Am J Gastroenterol; 1995 May; 90(5):845-6. PubMed ID: 7733108
[No Abstract] [Full Text] [Related]
2. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
Sharma P; Sampliner RE; Camargo E
Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
[TBL] [Abstract][Full Text] [Related]
3. Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
Cooper BT; Chapman W; Neumann CS; Gearty JC
Aliment Pharmacol Ther; 2006 Mar; 23(6):727-33. PubMed ID: 16556174
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of Barrett esophagus with argon plasma coagulation with acid suppression--a prospective study].
Martin WR; Jakobs R; Spiethoff A; Maass S; Riemann JF
Z Gastroenterol; 1999 Sep; 37(9):779-84. PubMed ID: 10522363
[TBL] [Abstract][Full Text] [Related]
5. Acid control and regression of Barrett's esophagus: is the glass half full or half empty?
Castell DO; Katz PO
Am J Gastroenterol; 1997 Dec; 92(12):2329-30. PubMed ID: 9399786
[No Abstract] [Full Text] [Related]
6. Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus.
Nishi T; Makuuchi H; Weinstein WM
Tokai J Exp Clin Med; 2005 Jul; 30(2):117-21. PubMed ID: 16146202
[TBL] [Abstract][Full Text] [Related]
7. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus.
Sampliner RE
Am J Gastroenterol; 1994 Oct; 89(10):1844-8. PubMed ID: 7942680
[TBL] [Abstract][Full Text] [Related]
8. 24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors.
Ortiz A; MartÃnez de Haro LF; Parrilla P; Molina J; Bermejo J; Munitiz V
Br J Surg; 1999 Nov; 86(11):1472-4. PubMed ID: 10583299
[TBL] [Abstract][Full Text] [Related]
9. [Choice of proton pump inhibitors--does it play any role?].
Hellström PM
Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2620-1. PubMed ID: 15534636
[No Abstract] [Full Text] [Related]
10. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
11. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
12. Barrett's esophagus: acid suppression, but no regression.
Bozymski EM; Shaheen NJ
Am J Gastroenterol; 1997 Apr; 92(4):556-8. PubMed ID: 9128299
[No Abstract] [Full Text] [Related]
13. Reflux disease and Barrett's esophagus.
Haag S; Holtmann G
Endoscopy; 2003 Feb; 35(2):112-7. PubMed ID: 12561004
[TBL] [Abstract][Full Text] [Related]
14. [Lansoprazole--profile of a new proton pump inhibitor].
Seifert E
Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
[TBL] [Abstract][Full Text] [Related]
15. The dose of omeprazole required to achieve adequate intraesophageal acid suppression in patients with gastroesophageal junction specialized intestinal metaplasia and Barrett's esophagus.
Watson JT; Moawad FJ; Veerappan GR; Bassett JT; Maydonovitch CL; Horwhat JD; Wong RK
Dig Dis Sci; 2013 Aug; 58(8):2253-60. PubMed ID: 23824407
[TBL] [Abstract][Full Text] [Related]
16. Is symptom control the correct end point for proton pump inhibitor treatment in Barrett's oesophagus?
Sarela AI; Verbeke CS; Pring C; Guillou PJ
Gut; 2004 Sep; 53(9):1387-8. PubMed ID: 15306606
[No Abstract] [Full Text] [Related]
17. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
Katz PO
Rev Gastroenterol Disord; 2006; 6(3):136-45. PubMed ID: 16957654
[TBL] [Abstract][Full Text] [Related]
18. Management strategies for Barrett's esophagus.
Hillman L
J Gastroenterol Hepatol; 2007 Jun; 22(6):771-2. PubMed ID: 17565627
[No Abstract] [Full Text] [Related]
19. The length of newly diagnosed Barrett's oesophagus and prior use of acid suppressive therapy.
El-Serag HB; Aguirre T; Kuebeler M; Sampliner RE
Aliment Pharmacol Ther; 2004 Jun; 19(12):1255-60. PubMed ID: 15191506
[TBL] [Abstract][Full Text] [Related]
20. [Rapidity of pain relief, medication requirement and patient satisfaction with reflux treatment in the physician's office].
Dohmen W; Fuchs W
MMW Fortschr Med; 2005 Mar; 147(9):39. PubMed ID: 15794353
[No Abstract] [Full Text] [Related]
[Next] [New Search]
